Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Debt to Equity (2016 - 2018)

Historic Debt to Equity for Anaptysbio (ANAB) over the last 4 years, with Q4 2018 value amounting to $0.0.

  • Anaptysbio's Debt to Equity fell 9476.69% to $0.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $0.0, marking a year-over-year decrease of 9476.69%. This contributed to the annual value of $0.0 for FY2018, which is 9476.69% down from last year.
  • Anaptysbio's Debt to Equity amounted to $0.0 in Q4 2018, which was down 9476.69% from $0.0 recorded in Q3 2018.
  • Over the past 5 years, Anaptysbio's Debt to Equity peaked at $0.12 during Q1 2017, and registered a low of -$0.36 during Q4 2016.
  • Moreover, its 4-year median value for Debt to Equity was $0.02 (2018), whereas its average is -$0.01.
  • In the last 5 years, Anaptysbio's Debt to Equity crashed by 15904.49% in 2016 and then soared by 10680.15% in 2017.
  • Anaptysbio's Debt to Equity (Quarter) stood at -$0.14 in 2015, then crashed by 159.04% to -$0.36 in 2016, then skyrocketed by 106.8% to $0.02 in 2017, then crashed by 94.77% to $0.0 in 2018.
  • Its Debt to Equity stands at $0.0 for Q4 2018, versus $0.0 for Q3 2018 and $0.01 for Q2 2018.